The complex economic revenue due to people who decide to give up their DNA for medical research has to be analyzed in depth. This is fundamental to understand the potential of every single sequenced genome. The first step is constituted by the genetic test. The genetic tests' sector is in substantial growth, thanks to the progressive cost reduction, as pointed out by a study conducted by National Human Genome Research.
According to Marketsandmarkets analysts, the genetic tests' market will reach the value of 17 billion dollars in the course of the next four years. Obviously, the expenses are on the buyer, who currently spends an amount ranging from 400 to 2000 dollars. After the sequencing, the genome gets framed in specific databases, usually managed by the same companies who provide the test.
At this point, everything gets handled by the big companies in the genomics market. The genomics market is divided into three principal segments: discovery, molecular diagnostics, and clinical tests. Every industry in this market draws tests and studies material from databases
According to Marketsandmarkets analysts, the genetic tests' market will reach the value of 17 billion dollars in the course of the next four years. Obviously, the expenses are on the buyer, who currently spends an amount ranging from 400 to 2000 dollars. After the sequencing, the genome gets framed in specific databases, usually managed by the same companies who provide the test.
At this point, everything gets handled by the big companies in the genomics market. The genomics market is divided into three principal segments: discovery, molecular diagnostics, and clinical tests. Every industry in this market draws tests and studies material from databases